See more : McLaren Resources Inc. (MCL.CN) Income Statement Analysis – Financial Results
Complete financial analysis of AK Medical Holdings Limited (1789.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AK Medical Holdings Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Anton Oilfield Services Group (3337.HK) Income Statement Analysis – Financial Results
- Zosano Pharma Corporation (ZSANQ) Income Statement Analysis – Financial Results
- The Brooker Group Public Company Limited (BTC.BK) Income Statement Analysis – Financial Results
- Ginlong Technologies Co., Ltd. (300763.SZ) Income Statement Analysis – Financial Results
- Jiangsu Tianmu Lake Tourism Co.,Ltd (603136.SS) Income Statement Analysis – Financial Results
AK Medical Holdings Limited (1789.HK)
About AK Medical Holdings Limited
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.09B | 1.05B | 761.44M | 1.04B | 926.71M | 600.56M | 372.70M | 270.78M | 206.16M | 148.28M |
| Cost of Revenue | 419.38M | 415.61M | 262.25M | 320.85M | 283.45M | 191.68M | 108.91M | 83.47M | 64.11M | 46.93M |
| Gross Profit | 674.49M | 636.44M | 499.19M | 714.53M | 643.25M | 408.88M | 263.79M | 187.31M | 142.06M | 101.35M |
| Gross Profit Ratio | 61.66% | 60.49% | 65.56% | 69.01% | 69.41% | 68.08% | 70.78% | 69.18% | 68.90% | 68.35% |
| Research & Development | 137.13M | 110.87M | 113.07M | 104.97M | 80.53M | 45.60M | 34.96M | 20.39M | 18.88M | 15.54M |
| General & Administrative | 133.44M | 118.31M | 105.32M | 83.02M | 92.20M | 74.13M | 56.22M | 50.29M | 32.03M | 19.28M |
| Selling & Marketing | 218.81M | 180.11M | 187.35M | 154.10M | 175.33M | 122.88M | 50.40M | 9.52M | 7.72M | 3.25M |
| SG&A | 352.25M | 298.42M | 292.66M | 237.12M | 267.54M | 197.00M | 106.62M | 59.81M | 39.75M | 22.53M |
| Other Expenses | -26.37M | -11.19M | -5.98M | -5.33M | -7.49M | -4.94M | -2.68M | 13.74M | 10.47M | 5.49M |
| Operating Expenses | 463.00M | 398.09M | 399.75M | 336.76M | 340.57M | 237.65M | 138.90M | 93.94M | 69.10M | 43.55M |
| Cost & Expenses | 882.38M | 813.70M | 662.01M | 657.61M | 624.03M | 429.34M | 247.81M | 177.41M | 133.21M | 90.49M |
| Interest Income | 22.77M | 17.75M | 8.99M | 12.96M | 10.14M | 5.15M | 1.12M | 467.00K | 2.33M | 2.42M |
| Interest Expense | 1.29M | 2.17M | 1.61M | 1.28M | 664.00K | 18.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 90.94M | 80.40M | 74.16M | 60.52M | 32.16M | 20.74M | 12.24M | 8.77M | 5.09M | 4.52M |
| EBITDA | 323.34M | 322.87M | 184.33M | 438.41M | 341.38M | 195.26M | 137.13M | 101.69M | 77.90M | 62.24M |
| EBITDA Ratio | 29.56% | 30.69% | 24.21% | 42.34% | 36.84% | 31.96% | 36.79% | 37.72% | 37.86% | 42.03% |
| Operating Income | 211.48M | 219.98M | 99.44M | 368.93M | 315.52M | 171.23M | 124.89M | 93.37M | 72.96M | 57.79M |
| Operating Income Ratio | 19.33% | 20.91% | 13.06% | 35.63% | 34.05% | 28.51% | 33.51% | 34.48% | 35.39% | 38.97% |
| Total Other Income/Expenses | 19.63M | 20.31M | 9.12M | 7.68M | 18.06M | 3.27M | -504.00K | 1.66M | 2.99M | 2.51M |
| Income Before Tax | 231.12M | 240.29M | 108.56M | 376.61M | 321.40M | 174.50M | 125.38M | 95.03M | 75.95M | 60.30M |
| Income Before Tax Ratio | 21.13% | 22.84% | 14.26% | 36.37% | 34.68% | 29.06% | 33.64% | 35.09% | 36.84% | 40.66% |
| Income Tax Expense | 49.01M | 35.52M | 15.94M | 62.60M | 54.41M | 29.56M | 20.01M | 17.70M | 11.04M | 8.58M |
| Net Income | 182.10M | 204.77M | 92.62M | 314.01M | 266.99M | 144.94M | 105.38M | 77.33M | 64.91M | 51.72M |
| Net Income Ratio | 16.65% | 19.46% | 12.16% | 30.33% | 28.81% | 24.13% | 28.27% | 28.56% | 31.48% | 34.88% |
| EPS | 0.16 | 0.18 | 0.08 | 0.28 | 0.26 | 0.14 | 0.14 | 0.08 | 0.06 | 0.05 |
| EPS Diluted | 0.16 | 0.18 | 0.08 | 0.28 | 0.25 | 0.14 | 0.14 | 0.08 | 0.06 | 0.05 |
| Weighted Avg Shares Out | 1.11B | 1.11B | 1.11B | 1.10B | 1.04B | 1.04B | 758.22M | 1.00B | 1.00B | 1.00B |
| Weighted Avg Shares Out (Dil) | 1.12B | 1.12B | 1.12B | 1.11B | 1.06B | 1.05B | 758.93M | 1.00B | 1.00B | 1.00B |
Source: https://incomestatements.info
Category: Stock Reports